The Time is NOW! Join the Fight to Bring Hope to HD Families: Urge the FDA to Uphold Accelerated Approval!

HDSA, Help4HD, HD Reach, HDF and HDYO have joined forces on a petition directly to the FDA.

bit.ly/Hope4HD

📝Sign Today! Don’t forget to confirm your email to make it count.

Three promising Young Investigators are in the spotlight
for their HDF-funded projects. Could this lead to answers for future treatments? Join them in an exciting exploration of their science! REGISTER NOW to learn more on Tuesday, 11/18, 12-1pm ET: us06web.zoom.us/webinar/regi...

HDF-funded Young Investigators are diving into therapeutic delivery strategies, targeting disease modifiers, & researching protein clumping. Results may lead to new breakthroughs in HD science. REGISTER NOW to learn more on Tuesday, 11/18, 12-1pm ET: us06web.zoom.us/webinar/regi...

Watch anytime! Our $1m Transformative Research Award recipients are pursuing innovative strategies to target the triggers of HD & open new pathways for potential treatments. Learn more: hdfoundation.org/webinars-eve...

Thanks to our sponsors, #IonisPharmaceuticals #ClevelandClinic #Novartis #Rgenta

This is an exciting time for the HDF - learn more at hdfoundation.org
#curehd

Researchers have discovered genetic "messages" that may appear only when HD is active. Would silencing these messages stop HD? Learn more on Wed, 9/17, 12-1pm ET. Register: tinyurl.com/9-2025-webinar
Thanks to our sponsors, #IonisPharmaceuticals #ClevelandClinic #Novartis #Rgenta #researchspotlight

HDF 2024 Transformative Research Award winners uncovered 2 genetic clues only in people with HD with treatment potential. Learn more on Wed, 9/17, 12-1pm ET.
Register: tinyurl.com/9-2025-webinar
Thanks to our sponsors, #IonisPharmaceuticals #ClevelandClinic #Novartis #Rgenta #researchspotlight

Congrats @jcarroll42.bsky.social, 2025 recipient of the Leslie Gehry Prize for Innovation in Science! Jeff's personal connection to #Huntingtonsdisease has fueled an impactful scientific career and an unwavering commitment to the HD community. We're so proud!

Learn more: tinyurl.com/2025-Gehry-P...

Our $1m Transformative Research Award winners think beyond the htt gene by targeting new molecules that may drive the disease. Learn more on Wed, 9/17, 12-1pm ET.
Register: tinyurl.com/9-2025-webinar
Thanks to our sponsors, #IonisPharmaceuticals #ClevelandClinic #Novartis #Rgenta #researchspotlight

Can we treat HD by targeting its triggers? Join us on Wed, 9/17, 12-1pm ET to find out!
Webinar with Drs. Andrew Yoo & Osama Al Dalahmah. Live Q&A to follow.
Register: us06web.zoom.us/.../651.../W...
Thanks to our sponsors, #IonisPharmaceuticals #ClevelandClinic #Novartis #Rgenta #researchspotlight

An article from the lab of HDF Scientific Advisory Board Chair Dr. Leslie Thompson garners the cover of the prestigious journal Neuron. This new study takes a deep dive using cutting-edge single-cell and spatial genomics into how Huntington’s disease changes the brain over time.

We are pleased to announce Christopher E. Pearson, PhD, from the Hospital for Sick Children (SickKids)‪, Toronto, Canada, as the recipient of our $1 Million 2025 Transformative Research Award. @sickkidsto.bsky.social @utoronto.ca

Read the full press release: hdfoundation.org/2025-transfo...

HDF is currently accepting Letters of Intent for Postdoctoral Fellowships and Grants from researchers from around the world to advance the discovery and development of treatments for Huntington’s disease. Please visit our website: hdfoundation.org/apply/ to learn more. LOIs are due by 9/3/2025.